Vaxcyte
(NASDAQ) PCVX
Vaxcyte Financials at a Glance
Market Cap
$7.78B
Revenue (TTM)
$0.00
Net Income (TTM)
-$946.53M
EPS (TTM)
-$6.97
P/E Ratio
-7.73
Dividend
$0.00
Beta (Volatility)
0.84 (Low)
Dividend
$0.00
Beta (Volatility)
0.84 (Low)
Price
$53.59
Volume
68,975
Open
$52.33
Price
$53.59
Volume
68,975
Open
$52.33
Previous Close
$53.59
Daily Range
$52.33 - $55.88
52-Week Range
$29.08 - $65.00
Estimated Earnings Date
Aug 5, 2026
Dividend
$0.00
Beta (Volatility)
0.84 (Low)
Price
$53.59
Volume
68,975
Open
$52.33
Previous Close
$53.59
Daily Range
$52.33 - $55.88
52-Week Range
$29.08 - $65.00
Estimated Earnings Date
Aug 5, 2026
PCVX News
PCVX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Vaxcyte
Industry
Biotechnology
Sector
Health CareEmployees
507
CEO
Grant E. Pickering, MBA
Website
www.vaxcyte.comHeadquarters
San Carlos, CA 94070, US
PCVX Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
-32.51%
Return on Capital
-31.69%
Return on Assets
-28.27%
Earnings Yield
-12.94%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$7.78B
Shares Outstanding
144.40M
Volume
68.97K
Avg. Volume
1.44M
Financials (TTM)
Gross Profit
-$5.85M
Operating Income
-$1.09B
EBITDA
-$920.69M
Operating Cash Flow
-$769.93M
Capital Expenditure
-$1.76M
Free Cash Flow
-$771.68M
Cash & ST Invst.
$1.74B
Total Debt
$116.30M
Vaxcyte Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
-$5.85M
N/A
Gross Margin
0.00%
N/A
Market Cap
$7.78B
N/A
Market Cap/Employee
$18.79M
N/A
Employees
414
N/A
Net Income
-$320.62M
-127.8%
EBITDA
-$314.77M
-131.7%
Quarterly Fundamentals
Total Cash
$1.74B
+3.9%
Total Debt
$116.30M
+33.4%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$110.21M
+35.9%
Short Term Debt
$6.09M
-0.7%
Return on Assets
-28.27%
N/A
Return on Invested Capital
-35.05%
N/A
Free Cash Flow
-$295.42M
-53.0%
Operating Cash Flow
-$280.63M
-68.8%